NCT07362823Not yet recruiting
A Study on the Efficacy of the Metaverse Lifestyle Health Education Model Based on the Transtheoretical Model for Improving Quality of Life and Modifying Lifestyle in Colorectal Cancer Survivors
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
Colorectal cancer is a globally prevalent malignant tumor. Postoperative patients often face physical discomfort, psychological stress, and lack of healthy lifestyles. However, traditional health education models have limitations such as insufficient targeting and poor interactivity, making it difficult to meet their needs for full-cycle health management. This study is a multicenter randomized controlled trial, which plans to enroll 174 patients aged 18 years and above who have undergone radical resection for colorectal cancer, and randomly divide them into an experimental group and a control group at a ratio of 1:1. The experimental group will receive Transtheoretical Model (TTM)-based metaverse lifestyle health education (including phased course learning, metaverse immersive interaction, and WeChat group check-in supervision) with an intervention cycle of 1 months and follow-up until 3 months after the intervention; the control group will only receive routine paper-based education and outpatient follow-up. The study aims to verify the improvement effect of this metaverse intervention model on the quality of life and healthy lifestyle of colorectal cancer survivors, and explore its role in improving patients' self-efficacy, so as to provide empirical evidence for optimizing long-term health management programs for cancer survivors.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 174 (estimated)
- First submitted
- 27 Dec 2025
- Start date
- 20 Jan 2026
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Qu Shen
- Diseases
- Colorectal cancer
- NCT number
- NCT07362823
What you commit to
- Study type: Interventional
- Planned participants: 174
- From 20 Jan 2026 to the primary completion date, 30 Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with other types of malignant tumors
- Patients with dysfunction of important organs such as heart, liver and kidney, or with unstable/rapidly deteriorating conditions
- Patients with severe cognitive impairment who cannot communicate normally and cooperate with the intervention
Other
- Patients with incompletely resected tumors or distant metastases
Who the study is looking for
- Patients with first diagnosed colorectal cancer who have undergone radical surgical treatment
- Aged ≥18 years old and non-pregnant
- Have basic communication, reading and comprehension abilities, and can proficiently use smartphones and WeChat
- Voluntarily sign the informed consent form and promise to cooperate in completing all interventions and follow-up assessments
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.